References

[1] Ibrahim, H. R., Ahmed, A. S., Miyata, T. (2017). Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk. Journal of Advanced Research, 8: 63-71.

[2] Collins, R., MacMahon, S. (1994). Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. British Medical Bulletin, 50: 272-298. 

[3] Collins, R., Peto, R., MacMahon, S., Hebert, P., Fiebach, N. H., Eberlein, K. A. (1990). Blood pressure, stroke, and coronary heart disease. Lancet, 335(8693): 827-838.

[4] Duprez, D., Helshoecht, P. V., Eynde, W. V., Leeman, M. (2002). Prevalance of hypertension in the adult population of Belgium: Report of a worksite study, Attention Hypertension. Journal of Human Hypertension, 16: 47-52. 

[5] James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennisonhimmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O. (2014). Evidence-based guideline for the management of high blood pressure in adults. The Journal of the American Medical Association, 311: 507-520. 

[6] Grandi, A. M., Gaudio, G., Fachinetti, A., Bianchi, L., Nardo, B., Zanzi, P., Ceriani, L., Guasti, L., Venco, A. (1996). Hyper-insulinemia, family history of hypertension, and essential hypertension. American Journal of Hypertension, 9: 732-738. 

[7] Cushman, D. W., Cheung, H. S. (1971). Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochemical Pharmacology, 20: 1637-1638. 

[8] Skeggs, L. T., Kahn, J. R., Shumway, N. P. (1956). The preparation and function of the hypertension-converting enzyme. Journal of Experimental Medicine, 103: 295-299. 

[9] Ondetti, M. A., Rubin, B., Cushman, D. W. (1977). Design of specific inhibitors of Angiotensin-Converting Enzyme: New class of orally active antihypertensive agents. Science, 196: 441-444. 

[10] Nakamura, Y., Masuda, O., Takano, T. (1996). Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneous hypertensive rats. Bioscience, Biotechnology, and Biochemistry, 60: 488-489. 

[11] Pihlanto-Leppala, A. (2001). Bioactive peptides derived from bovine whey proteins: Opioid and ACE-inhibitory peptides. Trends in Food Science and Technology, 11: 347-356. 

[12] Leclerc, P. L., Gauthier, S. F., Bachelardb, H., Santure, M., Roy, D. (2002). Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus. International Dairy Journal, 12: 995-1004. 

[13] Angelo, A., Marco, C. (2001). Drug-induced angioedema without urticarial. Drug Safety, 24: 599-606. 

[14] Chen, J., Wang, Y., Ye, R., Wu, Y., Xia, W. (2013). Comparison of analytical methods to assay inhibitors of angiotensin I-converting enzyme. Food Chemistry, 141: 3329-3334. 

[15] Matsui, T., Matsufuji, H., Osajima, Y. (1992). Colorimetric measurement of angiotensin I-converting enzyme inhibitory activity with trinitrobenzene sulfonate. Bioscience, Biotechnology, and Biochemistry, 56: 517-518. 

[16] Maruyama, S., Mitachi, H., Awaya, J., Kurono, M., Tomizuka, N., Suzuki, H. (2006). Angiotensin-I-converting enzyme inhibitory activity of the C-terminal hexapeptide of αs1-casein. Bioscience, Biotechnology, and Biochemistry, 51: 2557-2561. 

[17] Hernandezledesma, B., Recio, I., Ramos, M., Amigo, L. (2002). Preparation of ovine and caprine β-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine β-lactoglobulin hydrolysed with thermolysin. International Dairy Journal, 12: 805-812. 

[18] Daskaya-Dikmen, C., Yucetepe, A., Karbancioglu-Guler, F., Daskaya, H., Ozcelik, B. (2017). Angiotensin-I-Converting Enzyme (ACE)-inhibitory peptides from plants. Nutrients, 9(4): 316. doi: 10.3390/nu9040316. PMID: 28333109; PMCID: PMC5409655.

[19] Padghan, P., Mann, B., Sharma, R., Bajaj, R., Saini, P. (2017). Production of Angiotensin-I-Converting-Enzyme-Inhibitory Peptides in Fermented Milks (Lassi) Fermented by Lactobacillus acidophillus with Consideration of Incubation Period and Simmering Treatment. International Journal of Peptide Research and Therapeutics, 23: 69-79.

[20] Gouda, K. G. M., Gowda, L. R., Rao, A. G. A., Prakash, V. (2006). Angiotensin I-Converting Enzyme Inhibitory Peptide Derived from Glycinin, the 11S Globulin of Soybean (Glycine Max). Journal of Agriculture Food Chemistry, 54: 4568-4573.

[21] Iwaniak, A., Minkiewicz, P., Darewicz, M. (2014). Food-Originating ACE Inhibitors, Including Antihypertensive Peptides, as Preventive Food Components in Blood Pressure Reduction. Comprehensive Reviews in Food Science and Food Safety, 13: 114-134.

[22] Boschin, G., Scigliuolo, G. M., Resta, D., Arnoldi, A. (2014). ACE-Inhibitory Activity of Enzymatic Protein Hydrolysates from Lupin and Other Legumes. Food Chemistry, 145: 34-40.

[23] Parrot, S., Degraeve, D., Couria, C., and Martial-Gros, A. (2003). In vitro study on digestion of peptides in Emmental cheese: Analytical evaluation and influence on angiotensin I converting enzyme inhibitory peptides. Nahrung/Food, 47: 87-94.

[24] Jimsheena, V. K., Gowda, L. R. (2009). Colorimetric, high-throughput assay for screening Angiotensin I-converting enzyme inhibitors. Analytical Chemistry, 81(22), 9388-9394.

[25] Loizzo, M. R., Said, A., Tundis, R., Rashed, K., Statti, G. A,, Hufnerm A., Menichini, F. (2007). Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytotherapy Research, 21(1): 32-36. doi: 10.1002/ptr.2008. PMID: 17072829.

[26] Nyman, U., Joshi, P., Madsen, L., Pedersen, T. B., Pinstrup, M., Rajasekharan, S., George, V., Pushpangadan, P. (1998). Ethnomedical information and in-vitro screening for angiotensin converting enzyme inhibition of plants utilized as traditional medicines in Gujarat, Rajasthan and Kerala (India). Journal of Ethnopharmacology, 60: 247-263.